HOOKIPA Pharma Inc.
HOOK · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 239.1% | 48% | -71.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -19.5% | -750.4% | -1,798.9% | -279.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.3% | -769.8% | -1,842.7% | -294.3% |
| EPS Diluted | -0.4 | -1.23 | -1.99 | -1.1 |
| % Growth | 67.5% | 38.2% | -80.9% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |